Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes.
Marotte L, Simon S, Vignard V, Dupre E, Gantier M, Cruard J, Alberge JB, Hussong M, Deleine C, Heslan JM, Shaffer J, Beauvais T, Gaschet J, Scotet E, Fradin D, Jarry A, Nguyen T, Labarriere N.
Marotte L, et al. Among authors: deleine c.
J Immunother Cancer. 2020 Jan;8(1):e000311. doi: 10.1136/jitc-2019-000311.
J Immunother Cancer. 2020.
PMID: 32001504
Free PMC article.